MENU

Click here to

×

Are you sure ?

Yes, do it No, cancel

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

Education | IM | IM/TH | Leadership | TH | show all

Taxonomy: TH- response assessment : MR imaging-based

MO-C930-GePD-F2-1Assessment of the Treatment Response of Radiotherapy for Brain Metastases Using Arterial Spin Labeling Imaging
c Hou*, G Gong , Y Yin , ShanDong Cancer Hospital, Jinan, 37
PO-GePV-T-54Voxel-Level Analysis of Brain Imaging Changes in Nasopharynx Patients Treated with Proton Therapy
D Mirkovic1*, GM Engeseth1,3 , P Yepes2 , R Mohan1 , S Frank1 , A Adair1,2 , Q Wang2 , B Gunn1 , (1) U.T M.D. Anderson Cancer Center, Houston, TX, (2) Rice University, Houston, TX, (3) Haukeland University Hospital, Bergen, Norway
SU-K-225BCD-3Intravoxel Incoherent Motion Imaging and MR Texture Analysis of Healthy and Diseased Tissue During Stereotactic Body Radiotherapy of Liver Cancer
B Lewis1*, E Fields1 , S Kim1 , T Kim2 , (1) Virginia Commonwealth University, Richmond, VA, (2) Washington University in St. Louis, Saint Louis, MO
TH-A-SAN2-9Mid-Treatment Gd-EOB-DTPA-Enhanced MRI and Interleukin 6 Cytokine as Biomarkers of Radiation-Induced Liver Toxicity in Metastatic Liver Patients
A Ajdari1*, Y Xie1 , C Richter2 , T Hong1 , T Bortfeld1 , (1) Massachusetts General Hospital, Boston, MA, (2) OncoRay, Dresden, Germany
TH-BC-225BCD-9BEST IN PHYSICS (MULTI-DISCIPLINARY): Rapid Multi-Contrast Brain Imaging at 0.35T to Facilitate Tumor Response Assessment and Functional Adaptive Radiation Therapy
N. Zakariaei1*, Y. Chen2, S Nejad-Davarani 3, E.M. Haacke1,4, C Glide-Hurst1,3 (1) Wayne State University, Detroit, MI, (2) Wayne State University School of Medicine, Detroit, (3) Henry Ford Cancer Institute, Detroit, MI (4) The MRI Inst. for Biomedical Research, Detroit, MI
WE-AB-225BCD-10The Influence of SABR Fractionation and Imaging Delay Time On Post-Radiotherapy DCE-MRI Response Assessment in Early Stage Breast Cancer Patients
M Mouawad1,2,3*, H Biernaski2 , M Brackstone3,4 , M Lock3,4 , B Yaremko3,4 , O Shmuilovich2 , A Kornecki2 , I Nachum2 , F S. Prato1,2 , R. T. Thompson1,2 , S Gaede1,2,3,4 , N Gelman1,2,4 , (1) Western University, London, ON, (2) Lawson Health Research Institute, London, ON, (3) London Regional Cancer Program, London, ON, (4) London Health Sciences Center, London, ON